ÌÇÐÄÆƽâ°æ

AbbVie is an international pharmaceutical company with a multitude of pharmaceutical products available. In 2025, for the first time after many years, the company’s major revenue-generating drug was not Humira. In that year, Humira generated about *** U.S. dollars in revenue for AbbVie. Humira is used to treat several types of autoimmune diseases, including certain types of arthritis and Crohn’s disease. 

AbbVie’s company profile

Abbvie was founded in 2013, originally a spin-off of Abbott Laboratories, and is based in Chicago, Illinois, in the United States. In recent years, the company has experienced some growth, which can also be seen in its increasing number of employees. The company has also experienced exceptional growth in its annual revenues. Finally, AbbVie has experienced significant growth in its total assets in recent years. 

AbbVie’s global positioning

Despite being a young company, AbbVie is among the top pharmaceutical companies. AbbVie is placed among other top companies, such as Pfizer and Johnson & Johnson, in terms of their prescription sales and expenditure on research and development. The company is also among the top pharmaceutical companies in terms of its net profits per employee.